• GSK621: Uncovering AMPK-Driven Immunometabolic Reprogramming

  2026-06-05

  Explore how the potent AMPK agonist GSK621 enables advanced research into immunometabolic reprogramming and apoptosis induction in AML cells. This article reveals deeper mechanistic insights and practical assay guidance beyond existing literature.

• WP1066: Redefining JAK2/STAT3 Modulation in Translational Re

  2026-06-05

  Explore the mechanistic, experimental, and translational landscape of WP1066—a potent, cell-permeable JAK2/STAT3 inhibitor—across oncology and regenerative medicine. This thought-leadership article addresses pathway rationale, evidence-backed protocols, emerging competitive strategies, and the future horizon for translational researchers pursuing next-generation therapeutics.

• EdU Flow Cytometry Assay Kits (Cy3): Precision in DNA Replic

  2026-06-04

  EdU Flow Cytometry Assay Kits (Cy3) deliver high-fidelity detection of S-phase DNA synthesis, outperforming traditional BrdU protocols for cell proliferation studies. This article details experimental workflows, advanced troubleshooting, and actionable insights from the latest breast cancer research—empowering researchers to achieve reproducible, multiplexed cell cycle analysis.

• EZ Cap™ Firefly Luciferase mRNA (5-moUTP): Mechanism & Bench

  2026-06-04

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) is a next-generation, 5-moUTP-modified, in vitro transcribed mRNA reporter enabling robust expression and immune-silenced bioluminescent assays. Its Cap 1 structure and optimized poly(A) tail deliver enhanced stability and translation efficiency for gene regulation and mRNA delivery studies.

• GSK621: AMPK Agonist Workflows for AML & Immunometabolic Res

  2026-06-03

  GSK621, a potent AMPK agonist from APExBIO, delivers unparalleled control over metabolic reprogramming and cell fate in acute myeloid leukemia (AML) and immunometabolic assays. This article details hands-on protocols, troubleshooting, and advanced applications for maximizing AMPK pathway interrogation and translational impact.

• Distinct Shh and Fgf10 Roles in Penile Development: Guinea P

  2026-06-03

  This study elucidates species-specific mechanisms of penile urethral and prepuce formation by comparing gene expression and functional outcomes in guinea pigs and mice. The findings reveal that differential regulation of Shh and Fgf10/Fgfr2 underlies divergent developmental pathways, offering new perspectives for translational developmental biology and teratogenicity research.

• Docosahexaenoic Acid (DHA): Beyond Neuroprotection to Immune

  2026-06-02

  Explore the multifaceted role of Docosahexaenoic Acid (DHA) as a neuroprotective and anti-inflammatory omega-3 fatty acid, and discover its emerging potential in immune modulation. This article provides a deep dive into DHA's mechanisms, protocol parameters, and how it uniquely bridges neural, visual, and immunological research.

• Morphological Profiling Reveals HSBP7 Rescue in Titin Cardio

  2026-06-02

  This study introduces CARDIO, a robust imaging-based assay to profile morphological and functional changes in human iPSC-derived cardiomyocytes. Through genome editing and high-content analysis, the authors identify HSBP7 loss as a surprising rescue mechanism in titin-deficient cardiomyopathy, highlighting the potential for morphological screening to uncover therapeutic targets.

• Silymarin: Milk Thistle Extract for Oxidative Stress Researc

  2026-06-01

  Silymarin is a polyphenolic complex from milk thistle seeds, widely used as a bioactive reference for oxidative stress and cancer research. Its robust antioxidant and anti-inflammatory properties are well-characterized, with precise solubility and storage parameters supporting reproducible bench workflows.

• Genetically Encoded NADH/NAD+ Redox Biosensor in Bacteria

  2026-06-01

  The reference study introduces a ratiometric, genetically encoded biosensor for real-time, high-throughput measurement of the NADH/NAD+ redox state in bacteria. This innovation enables systematic dissection of metabolic pathways and rapid screening for redox-altering genetic changes, providing researchers with a powerful tool for metabolic engineering and physiological studies.

• EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Red Fluorescent mRNA Ben

  2026-05-31

  EZ Cap™ mCherry mRNA (5mCTP, ψUTP) enables robust, low-immunogenic red fluorescent protein mRNA expression. Incorporating Cap 1 structure and modified nucleotides, it sets a reproducibility standard for reporter gene mRNA applications. Its design advances mRNA stability and translation efficiency for sensitive, reproducible cell assays.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-05-30

  Oliveira et al. (2025) demonstrate that naturally occurring angiotensin peptides, including shorter fragments such as Angiotensin 1/2 (5-7), significantly enhance SARS-CoV-2 spike protein binding to the AXL receptor. These findings provide new insight into the intersection of renin-angiotensin system signaling and COVID-19 pathogenesis, highlighting emerging research pathways for both cardiovascular and viral infection studies.

• Uridine, Trisodium Salt: Enabling Precision RNA Engineering

  2026-05-29

  Explore how Uridine, Trisodium Salt accelerates translational breakthroughs in RNA biosynthesis and genome engineering. This thought-leadership article synthesizes mechanistic insight and strategic guidance for researchers, drawing on the latest advances in RNA-mediated transgene insertion and the competitive landscape of gene editing tools. Discover protocol parameters, application maturity, and a forward-looking vision for integrating nucleoside analogs into next-generation translational workflows.

• Coumestrol Induces Ferroptosis in RA Synoviocytes via PMAIP1

  2026-05-29

  The reference study reveals that Coumestrol, a phytoestrogen estrogen receptor antagonist, induces ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes by stabilizing mitochondrial PMAIP1 through TRIM3 suppression. This mechanistic insight highlights a promising therapeutic approach for targeting synovial proliferation and inflammation in RA.

• EPI-001: Advancing Androgen Receptor Inhibition for Prostate

  2026-05-28

  Discover how EPI-001, a leading androgen receptor N-terminal domain inhibitor, is transforming prostate and breast cancer research through its unique mechanism and translational applications. This article explores in-depth scientific insights, protocol guidance, and the latest evidence from AR-driven cancer models.

15160 records 1/1011 page Next 12345 下5页 Last page